FDA Clearance Tracker · P080012-S023
PROMETRA PROGRAMMABLE INFUSION PUMP SYSTEM
Last checked: Nov 20, 2026Latest source record: Jul 29, 2015 (this decision)Source: openFDAMethods & limitations
Decided
Jul 29, 2015
Approved
Time to decision
317 days
Received Sep 15, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P080012-S023
- Device name
- PROMETRA PROGRAMMABLE INFUSION PUMP SYSTEM
- Applicant
- Infusyn Therapeutics, LLC
- Applicant location
- Hackettstown, NJ
- Received
- Sep 15, 2014
- Decided
- Jul 29, 2015
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P080012
Device type
- Device class
- Class III
- Specialty
- Hospital Medicine & Nursing
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE PATIENT THERAPY CONTROLLER AND CONFIGURATION DEVICE FOR USE WITH THE PROMETRA PROGRAMMABLE INFUSION SYSTEM.
Source documents
Other decisions for Infusyn Therapeutics, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Prometra Programmable Infusion Pump SystemPMA supplement
P080012-S068 · Decided Jan 12, 2022 · 433 days after receipt · Panel Track
Device type: Pump, infusion, implanted, programmable (LKK) · Hospital Medicine & Nursing
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.